Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hockley

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Vaccine|September 1, 1984
Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virionsC R Crawford, F A Mukhlis, R Jennings, et al.
In Vitro Cellular & Developmental Biology. Animal|July 23, 2003
Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assaysRoland A Fleck, Harpinder Athwal, Jane A Bygraves, et al.
Biomaterials|August 6, 1998
Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccinesA G Coombes, D Major, J M Wood, et al.
Journal of Virological Methods|April 26, 2005
Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigationsM A Afzal, V Dussupt, P D Minor, et al.
Journal of Virology|May 1, 1997
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17P M Cannon, S Matthews, N Clark, et al.
Lancet (London, England)|August 19, 1978
Isolation of an infectious agent from bone-marrows of patients with multiple sclerosisD N Mitchell, J S Porterfield, R Micheletti, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 31, 1976
Coagulation studies in long-term survivors after renal allograft transplantationE D Gomperts, J J Judelman, J Hockley, et al.
Lancet (London, England)|August 25, 1979
Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosisD N Mitchell, K K Goswami, P Taylor, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Vaccine|September 1, 1984
Use of zwitterionic detergent for the preparation of an influenza virus vaccine. 1: Preparation and characterization of disrupted virionsC R Crawford, F A Mukhlis, R Jennings, et al.
In Vitro Cellular & Developmental Biology. Animal|July 23, 2003
Optimization of nb-4 and hl-60 differentiation for use in opsonophagocytosis assaysRoland A Fleck, Harpinder Athwal, Jane A Bygraves, et al.
Biomaterials|August 6, 1998
Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccinesA G Coombes, D Major, J M Wood, et al.
Journal of Virological Methods|April 26, 2005
Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigationsM A Afzal, V Dussupt, P D Minor, et al.
Journal of Virology|May 1, 1997
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17P M Cannon, S Matthews, N Clark, et al.
Lancet (London, England)|August 19, 1978
Isolation of an infectious agent from bone-marrows of patients with multiple sclerosisD N Mitchell, J S Porterfield, R Micheletti, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 31, 1976
Coagulation studies in long-term survivors after renal allograft transplantationE D Gomperts, J J Judelman, J Hockley, et al.
Lancet (London, England)|August 25, 1979
Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosisD N Mitchell, K K Goswami, P Taylor, et al.
Pageof 8